[{"address1": "82 Richmond Street East", "city": "Toronto", "state": "ON", "zip": "M5C 1P1", "country": "Canada", "phone": "888-846-3171", "website": "https://www.pharmather.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Fabio  Chianelli", "age": 46, "title": "Founder, Chairman & CEO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 258959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carmelo  Marrelli ACIS, B.Comm., C.A., C.P.A., CGA, CPA", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 57669, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Todd", "age": 66, "title": "Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.288, "open": 0.29785, "dayLow": 0.287, "dayHigh": 0.3133, "regularMarketPreviousClose": 0.288, "regularMarketOpen": 0.29785, "regularMarketDayLow": 0.287, "regularMarketDayHigh": 0.3133, "payoutRatio": 0.0, "beta": 3.542, "volume": 78648, "regularMarketVolume": 78648, "averageVolume": 644795, "averageVolume10days": 1366850, "averageDailyVolume10Day": 1366850, "bid": 0.287, "ask": 0.29, "bidSize": 51552, "askSize": 19900, "marketCap": 25670540, "fiftyTwoWeekLow": 0.115, "fiftyTwoWeekHigh": 0.55, "fiftyDayAverage": 0.31498, "twoHundredDayAverage": 0.193685, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 24410486, "profitMargins": 0.0, "floatShares": 70975472, "sharesOutstanding": 88519104, "heldPercentInsiders": 0.19469999, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 88609000, "bookValue": 0.014, "priceToBook": 20.714285, "lastFiscalYearEnd": 1717113600, "nextFiscalYearEnd": 1748649600, "mostRecentQuarter": 1740700800, "netIncomeToCommon": -1477919, "trailingEps": -0.04, "enterpriseToEbitda": -17.658, "52WeekChange": 0.87096775, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 0.29, "recommendationKey": "none", "totalCash": 1291909, "totalCashPerShare": 0.015, "ebitda": -1382365, "totalDebt": 0, "quickRatio": 4.356, "currentRatio": 4.356, "returnOnAssets": -0.38985002, "returnOnEquity": -0.76141, "freeCashflow": -758513, "operatingCashflow": -1238787, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "PHRRF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": 0.6944459, "regularMarketPrice": 0.29, "marketState": "CLOSED", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1610116200000, "corporateActions": [], "regularMarketTime": 1755892800, "exchange": "OQB", "messageBoardId": "finmb_671235862", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "regularMarketChange": 0.002000004, "regularMarketDayRange": "0.287 - 0.3133", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 644795, "fiftyTwoWeekLowChange": 0.17499998, "fiftyTwoWeekLowChangePercent": 1.521739, "fiftyTwoWeekRange": "0.115 - 0.55", "fiftyTwoWeekHighChange": -0.26000002, "fiftyTwoWeekHighChangePercent": -0.4727273, "fiftyTwoWeekChangePercent": 87.09677, "earningsTimestampStart": 1745524800, "earningsTimestampEnd": 1745524800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.04, "fiftyDayAverageChange": -0.024980009, "fiftyDayAverageChangePercent": -0.07930665, "twoHundredDayAverageChange": 0.096315, "twoHundredDayAverageChangePercent": 0.4972765, "shortName": "PharmaTher Holdings Ltd.", "longName": "PharmaTher Holdings Ltd.", "market": "us_market", "esgPopulated": false, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Newscope Capital Corporation", "nameChangeDate": "2025-08-22", "cryptoTradeable": false, "displayName": "PharmaTher", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]